#AANAM – CLES Led to Sustained Reductions in ‘Off’ Time

#AANAM – CLES Led to Sustained Reductions in ‘Off’ Time

292377

#AANAM – CLES Led to Sustained Reductions in ‘Off’ Time

Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Carbidopa/levodopa enteral suspension (CLES) provided long-term, sustained, and clinically meaningful reductions in “off” time for people with Parkinson’s disease, according to data from a real-world study in the U.S. The two-year data also showed that controlling motor symptom fluctuations was associated with meaningful improvements in patients’ quality of life,…

You must be logged in to read/download the full post.